4.1 Article

EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation

H Gouda et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Review Respiratory System

Smads as intracellular mediators of airway inflammation

DA Groneberg et al.

EXPERIMENTAL LUNG RESEARCH (2004)

Article Physiology

Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis

N Venkatesan et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)

Article Biochemistry & Molecular Biology

Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β

G von Gersdorff et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Critical Care Medicine

Idiopathic pulmonary fibrosis - Impact of oxygen and colchicine, prednisone, or no therapy on survival

WW Douglas et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)